CHEMOMAB THERAPEUTICS LTD (CMMB) Stock Overview
USA - NASDAQ:CMMB - US16385C2035 - ADR
CMMB Key Statistics, Chart & Performance
The current stock price of CMMB is 2.63 USD. In the past month the price decreased by -26.12%. In the past year, price decreased by -57.31%.
CMMB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.02 | 393.22B | ||
| AMGN | AMGEN INC | 13.11 | 153.97B | ||
| GILD | GILEAD SCIENCES INC | 14.53 | 139.58B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.62 | 98.23B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.05 | 63.14B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.16B | ||
| ARGX | ARGENX SE - ADR | 79.83 | 45.29B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.9 | 40.16B | ||
| INSM | INSMED INC | N/A | 30.65B | ||
| NTRA | NATERA INC | N/A | 24.59B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.73B | ||
| BIIB | BIOGEN INC | 8.79 | 20.62B |
Related stock screener links
About CMMB
Company Profile
Chemomab Therapeutics Ltd is a IL-based company operating in Biotechnology industry. Chemomab Therapeutics Ltd (formerly known as Anchiano Therapeutics Ltd) is a Israel-based clinical-stage biopharmaceutical company. The firm specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
Company Info
CHEMOMAB THERAPEUTICS LTD
Kiryat Atidim, Building 7
TEL AVIV-YAFO 02139 IL
CEO: Neil Cohen
Employees: 20
Phone: 972773310156
CHEMOMAB THERAPEUTICS LTD / CMMB FAQ
What is the stock price of CHEMOMAB THERAPEUTICS LTD today?
The current stock price of CMMB is 2.63 USD. The price decreased by -0.75% in the last trading session.
What is the ticker symbol for CHEMOMAB THERAPEUTICS LTD stock?
The exchange symbol of CHEMOMAB THERAPEUTICS LTD is CMMB and it is listed on the Nasdaq exchange.
On which exchange is CMMB stock listed?
CMMB stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CHEMOMAB THERAPEUTICS LTD stock?
9 analysts have analysed CMMB and the average price target is 30.26 USD. This implies a price increase of 1050.57% is expected in the next year compared to the current price of 2.63. Check the CHEMOMAB THERAPEUTICS LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CHEMOMAB THERAPEUTICS LTD worth?
CHEMOMAB THERAPEUTICS LTD (CMMB) has a market capitalization of 49.59M USD. This makes CMMB a Nano Cap stock.
How many employees does CHEMOMAB THERAPEUTICS LTD have?
CHEMOMAB THERAPEUTICS LTD (CMMB) currently has 20 employees.
What are the support and resistance levels for CHEMOMAB THERAPEUTICS LTD (CMMB) stock?
CHEMOMAB THERAPEUTICS LTD (CMMB) has a support level at 2.62 and a resistance level at 4.94. Check the full technical report for a detailed analysis of CMMB support and resistance levels.
Should I buy CHEMOMAB THERAPEUTICS LTD (CMMB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CMMB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CMMB, evaluating the profitability, health, valuation and growth aspects
- CHEMOMAB THERAPEUTICS LTD (CMMB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CHEMOMAB THERAPEUTICS LTD (CMMB) Sales and EPS estimates to see what analysts future expectations are.
- CHEMOMAB THERAPEUTICS LTD (CMMB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CHEMOMAB THERAPEUTICS LTD (CMMB) Insider and Institutional Ownership to learn about the owners and their transactions.
- CHEMOMAB THERAPEUTICS LTD (CMMB) Stock Chart to make your own analysis
- CHEMOMAB THERAPEUTICS LTD (CMMB) Latest news and press-releases to stay up to date.
Does CHEMOMAB THERAPEUTICS LTD (CMMB) stock pay dividends?
CMMB does not pay a dividend.
When does CHEMOMAB THERAPEUTICS LTD (CMMB) report earnings?
CHEMOMAB THERAPEUTICS LTD (CMMB) will report earnings on 2025-11-12.
What is the Price/Earnings (PE) ratio of CHEMOMAB THERAPEUTICS LTD (CMMB)?
CHEMOMAB THERAPEUTICS LTD (CMMB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.76).
CMMB Technical Analysis
CMMB Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CMMB. While CMMB has a great health rating, there are worries on its profitability.
CMMB Financial Highlights
Over the last trailing twelve months CMMB reported a non-GAAP Earnings per Share(EPS) of -2.76. The EPS increased by 96.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -106.26% | ||
| ROE | -121.93% | ||
| Debt/Equity | 0 |
CMMB Forecast & Estimates
9 analysts have analysed CMMB and the average price target is 30.26 USD. This implies a price increase of 1050.57% is expected in the next year compared to the current price of 2.63.